Literature DB >> 2224226

Effect of erythropoietin in patients with myeloma.

S Rogers, N H Russell, A G Morgan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2224226      PMCID: PMC1663880          DOI: 10.1136/bmj.301.6753.667-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.

Authors:  J Taylor; R A Mactier; W K Stewart; I S Henderson
Journal:  BMJ       Date:  1990-09-08

2.  Recombinant human erythropoietin and hematopoietic progenitor cells in vivo.

Authors:  K Geissler; F Stockenhuber; E Kabrna; W Hinterberger; P Balcke; K Lechner
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

3.  Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo.

Authors:  E Dessypris; S E Graber; S B Krantz; W J Stone
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

4.  Erythropoietin treatment of anemia associated with multiple myeloma.

Authors:  H Ludwig; E Fritz; H Kotzmann; P Höcker; H Gisslinger; U Barnas
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

  4 in total
  2 in total

1.  Does erythropoietin accelerate malignant transformation in multiple myeloma?

Authors:  A Olujohungbe; S Handa; J Holmes
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

Review 2.  A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.

Authors:  Y Beguin
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.